November 18th, 2026Scripted for Her: Combatting Polyendocrine Metabolic Ovarian SyndromeLucy Andrews, PharmD, breaks down the new name for polycystic ovary syndrome and explains how pharmacists can help women get answers sooner.Read more
November 18th, 2026Severe Anemia Linked With Increase in Maternal Heart Failure RiskIron deficiency, which pharmacists often treat with OTC supplements and adherence counseling, may be an underrecognized contributor to heart failure in pregnancy.Read more
November 18th, 2026White House Withdraws Heidi Overton's Nomination as FDA CommissionerThe withdrawal came on the eve of a Senate committee vote, leaving the FDA without a nominee as vaccine and mifepristone debates continue.Read more
November 16th, 2026What Pharmacists Should Know About Shifting Peptide PolicyWith patients buying gray-market peptides, HHS’s draft policy aims to reunite prescribers, patients, and pharmacists around these emerging products.Read more
November 16th, 2026Gazyva Approved as First Drug for Primary Membranous NephropathyDespite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.Read more
November 16th, 2026FDA Expands Dexmedetomidine for At-Home UseFor patients with schizophrenia or bipolar I or II disorder, dexmedetomidine use will no longer require provider supervision.Read more
November 12th, 2026Doxycycline Use Associated with Higher Risk of Pregnancy LossThe medication significantly increased risk of pregnancy loss when compared with macrolide antibiotics, amoxicillin, and topical clindamycin for acne.Read more
November 11th, 2026FDA Approves Asundexian, First FXIa Inhibitor for Stroke PreventionA new option for adults who have experienced stroke will now be available to further reduce future risk.Read more